Skip to main content
Clinical Trials/DRKS00012910
DRKS00012910
Completed
Not Applicable

Impact of transcatheter valve implantation versus surgical valve replacement on aquired von Willebrand syndrome and platelet function in patients with aortic stenosis

niversitaets-Herzzentrum Freiburg Bad Krozingen Klinik für Kardiologie und Angiologie II0 sites120 target enrollmentOctober 5, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
I35.0
Sponsor
niversitaets-Herzzentrum Freiburg Bad Krozingen Klinik für Kardiologie und Angiologie II
Enrollment
120
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 5, 2017
End Date
August 16, 2016
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
niversitaets-Herzzentrum Freiburg Bad Krozingen Klinik für Kardiologie und Angiologie II

Eligibility Criteria

Inclusion Criteria

  • Indication for aortic valve replacement (bioprosthetic valve/CoreValve®/Edwards Sapien®), age \> 60 years, written informed consent

Exclusion Criteria

  • Prior valvular interventions or cardiac surgery, known severe disorder of the coagulation system, known hematologic disease, severe hepatopathy, hemodialysis, contraindication for treatment with TAVI, peri\- or postinterventional transfusions of fresh frozen plasma (FFP), platelets or coagulation factors

Outcomes

Primary Outcomes

Not specified

Similar Trials